Reservie(TM) Trans-Resveratrol 500mg
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 5-[(1E)-2-(4-hydroxyphényl)éthényl]-1,3-benzènediol Source : Resvératrol | 500 mg | Not calculated |
| Vitis vinifera Source : Vitis vinifera - Fruit Extract : Matériel brut frais Extraction ratio : 500:1 Dry plant equivalent : 1,000 mg | 2 mg | Not calculated |
| 2-(3,4-dihydroxyphényl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one Source : Quercétine dihydraté | 40 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropylméthylcellulose, Stéarate de magnésium, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Antioxidant. Provides Antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if pregnant or breastfeeding. If you are taking prescription medication, consult a healthcare practitioner prior to use as resveratrol may alter the effectiveness of these medications.
- Effets indésirables connus
May cause nausea, abdominal pain, and/or diarrhea.
Product record
- Licence holder
- VitaPath Canada Limited
- NPN or DIN-HM
- 80064715
- Status
- Inactive licence
- Licence date
- 21 October 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80064715
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Reservie(TM) Trans-Resveratrol 500mg”, https://compoatlas.com/en/supplements/canada/80064715-reservie-tm-trans-resveratrol-500mg, updated 21 October 2015.